Garheng Kong, MD, PhD, MBA

Garheng2.JPG

Garheng founded HealthQuest Capital in 2012 to improve people’s lives through improving healthcare on a significant scale.  His vision was to build a best-in-class team of the highest talent and integrity to work with outstanding entrepreneurs to transform healthcare through high growth companies while generating outsized risk adjusted returns for investors.

A physician, scientist, and engineer by training, Garheng has over two decades of experience investing in innovative healthcare companies with a long list of successes. He has served on the boards of HealthQuest portfolio companies Ajax I, Ajax II, Ajax III, Alcresta, Avedro, Avizia, BardyDx, Castle Biosciences, CleanSlate, Etairos, HealthChannels, Magnolia Medical, Spirox, Trice Medical, Venus, and CareMetx/VirMedica.

Some of his notable past successes include IPO’s with Avedro (AVDR), Castle Biosciences (CSTL), Cempra (CEMP), Alimera (ALIM), Applied Genetic Technology Corp. (AGTC), Proteon (PRTO), Histogenics (HSGX) and TransEnterix (TRXC). His investments going on to successful M&A transactions include: Ajax I (Medtronic), Avedro (Glaukos), Calibra Medical (J&J), Cellective (AstraZeneca), Serenex (Pfizer), Athenix (Bayer), NovaMin (GSK), Aldagen (Cytomedix), Salveo Specialty Pharmacy (United Health), SARCode (Shire), Spirox (Stryker), and Virmedica (CareMetx).

Garheng’s interests and industry footprint are broad as he also serves on the board of LabCorp (LH), Alimera Sciences (ALIM), StrongBridge (SBBP), Be The Match, the Duke University Medical Center, SEBIO, Corporate Chaplains of America and advises numerous industry groups such as IDEO and Lam Research. He is a Fellow of the Aspen Institute's Health Innovators Fellowship.

Garheng received undergraduate degrees in both Chemical Engineering and Biological Sciences from Stanford, while on an athletic scholarship. He then earned a MD, PhD and MBA from Duke University, graduating #1 in his class in each instance. His early career included stints at GlaxoSmithKline, McKinsey and a medical device start-up, TherOx, before joining Intersouth Partners and then Sofinnova Ventures. He is married to his physician wife (a board certified cardiac electrophysiologist), has 3 children, and was a nationally ranked volleyball player (and avid “foodie”).